Extrapulmonary tuberculosis in HIV-positive and HIV-negative children in Haiti: A hospital-based Investigation by Denis, Marie F
University of South Florida
Scholar Commons
Graduate Theses and Dissertations Graduate School
2005
Extrapulmonary tuberculosis in HIV-positive and
HIV-negative children in Haiti: A hospital-based
Investigation
Marie F. Denis
University of South Florida
Follow this and additional works at: http://scholarcommons.usf.edu/etd
Part of the American Studies Commons
This Thesis is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate
Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact scholarcommons@usf.edu.
Scholar Commons Citation
Denis, Marie F., "Extrapulmonary tuberculosis in HIV-positive and HIV-negative children in Haiti: A hospital-based Investigation"
(2005). Graduate Theses and Dissertations.
http://scholarcommons.usf.edu/etd/2854
Extrapulmonary Tuberculosis in HIV-Positive and HIV-Negative Children in Haiti:  
A Hospital-Based Investigation 
 
by 
 
Marie F. Denis 
 
 
A thesis submitted in partial fulfillment 
of the requirements for the degrees of 
Master of Science in Public Health 
Department of Epidemiology and Biostatistics 
and 
Master of Public Health 
Department of Global Health 
College of Public Health 
University of South Florida 
 
 
Co-Major Professor: Skai Schwartz, Ph.D. 
Co-Major Professor: Jeannine Coreil, Ph.D. 
John T. Sinnott, M.D. 
Yougui Wu, Ph.D.  
 
 
Date of Approval: 
November 18 , 2005 
 
 
 
Keywords: HIV, AIDS, pediatrics, osteomyelitis TB, lymph node TB, pleural TB, 
pericarditis TB, peritonitis TB 
 
© Copyright 2005, Marie F. Denis 
Dedication 
This thesis is dedicated to the children of CHOAIDS (Caring for Haitian Orphans with 
AIDS, inc.) and the USF College of Public Health.  In the fall of 2000, I started the 
Community of Family Health Program with the desire to serve; a little over a year into 
the program, I decided to get a master’s degree in Epidemiology.  I had no idea that in 
early 2004 I would start an orphanage in my homeland, Haiti, to provide care to HIV-
positive AIDS orphans.  As a Christian, I believe that God appointed me to do this work.  
I have learned so much from these children, but most of all, they have taught me to 
appreciate the simple things about life.  Living with this virus has not been easy for my 
angels, but I do hope that God will continue to provide for them through me so that I can 
continue to help in the alleviation of their pain by caring for them.  Haiti is an 
impoverished country plagued by civil unrest and disease; my goal is to help shape these 
young lives and others to become responsible adults who will contribute toward the 
building of the “new Haiti.”  Eleanor Roosevelt once said “do the thing that you think 
you cannot do.”  That’s my motto! 
 
 
Acknowledgments 
I would like to acknowledge my appreciation to the following persons and 
organizations for their support during my academic years working on my Master’s 
degrees: Dr. John T. Sinnott, who helped me develop the thesis topic and sat with me on 
several occasions narrowing my focus on the specifics.  This new line of research would 
not have been possible if it were not for Dr. Sinnott’s expertise.  Dr. Jeannine Coreil 
believed in me and provided me with something most people would not have the guts to 
give me - tough love.  I also extend my thanks to Dr. Skai Schwartz who helped me with 
the data analysis.  I would also like to thank the Department of Latin American and 
Caribbean Studies and the College of Public Health for their monetary support to travel to 
Haiti for the data collection process; without their grant, I would not have been able to 
afford to stay in Haiti for two months.  In addition, I would like to thank some people at 
Grace Children’s Hospital who greatly assisted me during the data collection process.  
Dr. Jeanu, without her “special notebook” to back-check the accuracy of my data, I 
would have made many mistakes.  She and Dr. Marie Florence Legros helped me to 
define a lot of French medical terms and some subtle nuances that were unfamiliar to me.  
I also need to give my appreciation to Mrs. Jocelyne Arnoux, for making sure that I was 
able to obtain almost everything I needed at the hospital and Dr. Frederic Vilme, for 
opening the hospital’s doors to me to do this work.  Also I give thanks to my husband 
Juan Luque for his love, support and understanding.  We make an excellent team. 
 
 
 
 
 
Table of Contents 
 
ABSTRACT........................................................................................................................ ii 
 
CHAPTER I  INTRODUCTION........................................................................................ 1 
Studies of TB Diagnosis ................................................................................................. 4 
Study Objectives ............................................................................................................. 8 
Background and Significance ......................................................................................... 8 
Country Profile.............................................................................................................. 11 
Historical Perspective and Pathomechanics of TB and HIV/AIDS.............................. 14 
Scientific Discoveries and Anti-TB Therapy............................................................ 15 
Transmission ............................................................................................................. 19 
Tuberculous Meningitis ............................................................................................ 20 
Osteomyelitis TB ...................................................................................................... 22 
Lymph node TB ........................................................................................................ 23 
 
CHAPTER II  HIV & AIDS ............................................................................................. 25 
Transmission and Diagnosis of TB and HIV in Children............................................. 26 
HIV Transmission in Children.................................................................................. 26 
Diagnosing HIV in Infants, Children, and Adolescents ........................................... 27 
Diagnosing TB in Infants, Children, and Adolescents ............................................. 29 
The Basics on Tuberculin Skin Tests and BCG Immunization ................................ 30 
 
CHAPTER III  METHODS.............................................................................................. 32 
Research Design............................................................................................................ 32 
Study Population........................................................................................................... 32 
Study Site ...................................................................................................................... 33 
Statistical Methods and Data Analysis ......................................................................... 34 
 
CHAPTER IV  RESULTS................................................................................................ 36 
 
CHAPTER V  DISCUSSION........................................................................................... 39 
 
TABLES ........................................................................................................................... 47 
REFERENCES ................................................................................................................. 52 
APPENDIX A................................................................................................................... 59 
 
i 
 
 
 
 
 
Extrapulmonary Tuberculosis in HIV-Positive and HIV-Negative Children in Haiti:  
A Hospital-Based Investigation 
Marie F. Denis 
ABSTRACT 
Introduction: Globally, one in four persons infected with the human immunodeficiency 
virus (HIV) who are living with the acquired immunodeficiency syndrome (AIDS) will 
die of tuberculosis (TB).  The estimated number of HIV-infected children who die of 
tuberculosis, especially extrapulmonary TB (EPTB), in Haiti, is only loosely based on 
facts or investigation.  This study proposes to describe demographics of children with 
EPTB in a pediatric TB hospital in Haiti.  The objectives are two-fold.  The first objective 
is to describe the population of children discharged from Grace Children’s Hospital with 
a confirmed diagnosis of tuberculosis overall, and broken down by whether or not the 
child had an extrapulmonary manifestation of the TB disease.  Specifically, we describe 
the demographic characteristics and the prevalence of HIV and other co-morbidities of 
the children, in-hospital mortality, and the diagnostic tools used to determine TB 
infection including the sputum test, and the documentation of family members also 
infected.  As part of the descriptive process, by examining those with only pulmonary TB 
(PTB) and EPTB separately, we investigate if they appear to be different sub-populations 
based on demographic characteristics and clinical measures.  The second objective of this 
work is to determine if there is a positive association between HIV infection and the 
EPTB manifestation in children with a confirmed diagnosis of TB, both crudely and after 
adjusting for demographic variables and co-morbidities.   
Methods: A cross-sectional study design was used to review medical charts of clinically 
diagnosed pediatric TB cases for a five-year period (January 1, 1999 – December 31, 
2003).  This included 492 pulmonary TB and 210 extrapulmonary TB cases.  Variables 
measured included clinical measures and demographic characteristics.   
Results: Data for 615 hospitalized, clinically diagnosed pediatric TB cases were 
reviewed. There were 315 (51.4%) males and 298 (48.6%) females with a mean age of 
5.40 years (range 0.17 - 14 years), with 214 (37.9%) of the patients aged 0-2 years.  
Percent males were 47.8% and 57.9% in PTB and EPTB groups respectively (p<0.05). 
One hundred and seven (17.4%) of patients were HIV positive.  Three hundred eighty-
eight (63%) of the patients had one or more additional co-morbidities: [anemia 299 
(48.6%), intestinal parasites 93 (15.1%), malaria 58 (9.4%) and gastroenteritis 19 
(3.1%)].  Nearly 85% of the children were undernourished.  Eighty-three child patients 
(13.5%) died in the hospital.  Children with EPTB were much more likely to be over the 
age of two (74% vs. 56% in PTB group), resulting in a highly significant Chi-square 
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statistic.  The overall difference in mean age, however, was only borderline significant 
with children with EPTB being slightly older [p=0.059] and age was only weakly 
associated with TB group. They were much less likely to be HIV positive (8.6% vs. 22%, 
p<0.01).  Children in the EPTB group were somewhat less likely to die in the hospital 
(10.0% vs. 15.4%, p=0.066).  The OR was greater than 4 for HIV and was greater than 2 
for poor nutrition status [p<0.01 for each].   
Conclusion:  There was no association in this model between EPTB and mortality.   The 
apparent univariate association between EPTB and reduced mortality can be explained by 
lower prevalence of HIV and poor nutrition status in this sub-sample.  This study has 
implications for hospital-based pediatric TB diagnosis and epidemiology in resource-poor 
countries. 
iii 
 
 
 
 
 
CHAPTER I  INTRODUCTION 
Haiti’s children are suffering.  There is an urgent documented need to augment 
the present health system, which lacks the capacity to diagnose, treat, or provide adequate 
preventative measures designed to improve the health of the general population, and 
especially, children.  This research will address the problems of TB and AIDS in 
children, and argue for increased resources to offset the loss of life resultant from the 
epidemic spread of TB and HIV/AIDS in Haiti. 
 Tuberculosis is a global health problem.  In 1993, the World Health Organization 
(WHO) declared it a global health emergency, and in 1999, estimation of global 
mycobacterium tuberculosis infection was approximated at two billion (Centers for 
Disease Control & Prevention, 1999; Houghton, 2002).1  According to WHO, 
tuberculosis kills approximately three million people and sickens eight million worldwide 
each year (Basel, 1998).  Every 15 seconds, one of every three persons to die from TB is 
a child (Mwinga, 2005).   
Children with HIV-infection are between five to ten times more likely to develop 
tuberculosis than HIV-negative children.  One-third of the increased number of TB cases 
is attributed to the spread of the human immunodeficiency virus (HIV) epidemic 
(UNAIDS, 2004a).2  Worldwide TB is the leading cause of death in HIV-infected 
persons, especially in developing countries.  In addition, among infectious diseases, 
                                                 
1 The infectious bacterium that causes TB. 
2 There are two types of HIV: HIV-1 and HIV-2 (Centers for Disease Control & Prevention, 1998). 
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tuberculosis is the second leading cause of mortality worldwide (CDC, 1999; Houghton, 
2002).3  Since one in four persons infected with HIV and living with the acquired 
immunodeficiency syndrome (AIDS) will die of TB disease and the leading cause of 
death in Haiti is AIDS-related, the estimation of the number of HIV-infected children 
who die of TB disease in Haiti has not been investigated.   
Haiti has both a high prevalence of HIV and a high endemicity of TB.  HIV 
infection damages the immune system and therefore compromises immune functions.  As 
the infection progresses to AIDS, EPTB becomes as frequent as PTB in patients, and 
adults with AIDS are known to have increased susceptibility to develop TB disease and 
for their TB disease to quickly progress to EPTB (Chan, Birnbaum, Rao, & Steiner, 1996; 
Yang et al., 2004).  Children and adults with AIDS are known to have similar AIDS-
related opportunistic infections.  The majority of HIV transmission occurs through 
heterosexual contacts in Haiti.  This is directly related to the increase in the nation's 
infant mortality rate.   
Accurate measures of HIV-infection and death occurring due to HIV-infection 
among Haitian children is very difficult to determine because of the lack of diagnostic 
tests for HIV in children, and incomplete definition of pediatric HIV clinical 
manifestations (Jean et al., 1997).  Just as it is for adults, HIV-infected children are at a 
greater risk of becoming infected with TB and thereby developing TB disease.   
Morbidity, mortality, and infection of others in the community with TB are 
minimized when symptoms are diagnosed and treatments are initiated early.  
Antiretroviral therapy became available to a select few of those with AIDS in Haiti in late 
2002, and identifying and treating HIV co-infected will reduce the transmission of the 
                                                 
2 
3 The third infectious disease and leading cause of death worldwide is malaria 
 
 
tubercle bacilli to infants, children, and other vulnerable persons in the population.  
Although pediatric EPTB is common, it is unresearched in Haiti because physicians lack 
basic resources to diagnose TB disease; thus they treat TB based on clinical suspicion or 
possible contact to an active TB case, rather than chest radiographs and bacteriologic 
tests.  
Isolating the mycobacterium tuberculosis in suspected pediatric cases (particularly 
infants) is very challenging because of the lack of sputum production and the atypical 
presentation of TB disease. Misdiagnosis of TB infection in children is common because 
some patients are asymptomatic and those with symptoms are nonspecific.  Decreasing 
the number of misdiagnoses among these cases will require clinicians in resource-poor 
areas to receive updated data including instructions on other AIDS-related lung diseases. 
This chapter begins with a review of the literature relating to studies of TB 
diagnosis, with an emphasis on pediatric cases.  Next, the background and significance of 
TB and HIV/AIDS is discussed in reference to the Caribbean.  The following section 
situates the problem of these diseases in Haiti and highlights key country indicators.  The 
second part of this chapter introduces the history and pathomechanics of TB and 
HIV/AIDS with a discussion of TB transmission, tuberculous meningitis, osteomyelitis 
TB, and lymph node TB. 
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Studies of TB Diagnosis  
 In a cross-sectional study conducted in a pediatric referral center in a TB endemic 
area of Peru, the investigators sought to provide a description of the epidemiology and 
clinical features of pulmonary TB in children.  Clinical features of manifested or 
suspected TB cases in children include the presentation of cough, a history of contact 
case, characteristic of chest radiographs, and purified protein derivative (PPD) reaction.  
With a sample size of 135 suspicious cases of pediatric TB, of patients aged 1 month to 
17 years, the researchers formed the following 3 groups: definitive TB, probable TB, and 
no TB.  Mycobacterium TB was isolated from sputum of 50 children and these children 
were considered to have TB; 35 children among that group were shown to have acid-fast 
bacilli (AFB) in sputum smear.  Probable TB cases were classified as those who met at 
least two or more of the Migliori clinical diagnostic criteria for pulmonary TB; 55 
children met the criteria; 30 children negative for TB.  Patients’ age, sex, BCG 
immunization and PPD reaction, the presence of extrapulmonary TB, and socioeconomic 
status were not significant in all the groups.   
 Extrapulmonary TB (lymphadenopathy, miliary disease, intestinal-intraperitonial 
TB, intra-abdominal, meningitis, and optic involvement) was present in 21 children 
(16%); characteristics of children with EPTB and those with PTB were similar with both 
groups including malnourished children.  Children with EPTB were younger than those 
children without signs and symptoms of EPTB.  In this study, the researchers determined 
children diagnosed with PTB were more likely to be symptomatic, without a positive skin 
test and specifics in chest radiographs.  Additionally, in infants, it was less likely that 
they will have a positive smear culture.  Improvement in diagnostic tools for pediatric TB 
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is necessary because historical and clinical data, which are currently considered as the 
gold standard used in developing countries, only comprise part of the diagnosis (Salazar 
et al., 2001). 
 HIV is a known risk factor that further complicates the treatment of the diagnosis 
of tuberculosis in children, especially infants.  Tuberculosis and HIV further aggravate 
diagnosis-related issues including, the absence of alternative sensitive diagnostic TB 
tests, lack of production of sputum samples in small children, the inconsistency of 
symptoms presentation in children, the lack of a standardized case definition used 
specifically for diagnosing TB in children, and the inclusion of small or limited number 
pediatric TB cases included in studies in the developed world.   
 In a two-design study conducted at two ambulatory centers in Abidjan, Cote 
d'Ivoire, investigators sought to present the importance of HIV infection as an 
independent risk factor for developing TB in children.  In a sample of 161 cases, of 
children aged 0-9 years who had already begun TB treatment, data collected included 
socioeconomic and demographic status, household environment, risk factors for TB, and 
the children's medical history.  Clinical examination performed was chest radiograph, 
tuberculin skin test, sputum smear and culture, HIV antibody test and lymphocyte 
phenotype.  The cases were gender and aged-matched to 161 controls of healthy siblings 
referred to the hospitals for tuberculin skin tests.  Among the 161 cases, 39 had 
confirmed pulmonary TB, 80 with clinical PTB, and 42 with clinical EPTB.  Moreover, 
31 children in that group were found to be HIV-positive, with 129 HIV-negative with no 
available HIV serologic result in 1 child.  HIV prevalence among all the three TB groups 
was not significant.  None of the controls were HIV-positive.   
5 
 
 
 Risk factors included, children with TB were more likely to be HIV-positive and 
to have had at least one contact with a TB patient, and to be living in very low 
socioeconomic status housing.  Clinical presentation of TB in both HIV-positive and 
HIV-negative children was also not significant, with confirmed clinical TB being lower 
in children with HIV-infection.  HIV-positive children in all three groups were less likely 
to have an induration of tuberculin skin test of greater or equal to 5mm and their results 
were similar to that of the control group.   It was suggested that the tuberculin skin test 
might not be a useful tool to diagnose TB in HIV-infected children.  This study shows 
that the manifestation of TB does not significantly differ between children who are HIV-
positive and those who are HIV-negative (Mukadi et al., 1997).    
 Because there are limited published data on pediatric HIV-infection and EPTB, 
the following point to the necessity and urgency for these studies.   In a retrospective 
study conducted in Malawi using national TB data, 11.9% of the sample size was 
pediatric cases.  This number represented 1.3% of all the reported cases; of those, 15.9% 
of the pediatric cases were EPTB.  Children between 1 to 4 years old were more likely to 
have EPTB than those less than one year and between 5 to 14 years old (88/ 100,000, 78/ 
100,000 and 33/ 100,000) (Harries et al., 2002).   
A Ugandan study showed EPTB occurred in 50% of patients under 14 years old in 
hospitalized cases for a five-year period (1985 - 1989) (Okot-Nwang, Wabwire-Mangen, 
& Kagezi, 1993).  HIV disease associated with EPTB constitutes 50% of all TB disease 
and includes lymphadenopathy, pleural effusion, pericardial disease, miliary, and 
meningitis (H. Hausler, 2000; Sharma & Mohan, 2004).   
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A study conducted in India among AIDS patients found that between 56% of TB 
disease cases were EPTB (Sharma & Mohan, 2004).   Another such study there, 
determined that nearly 55% of the HIV-infected children with EPTB had the disease in 
one or more sites, of those, 78% had both PTB and EPTB (Shahab, Zoha, Malik, Malik, 
& Afzal, 2004).  
Since the inception of the HIV epidemic in the United States, AIDS-related EPTB 
cases rose from 16% in 1991 to 20% in 2001 (Jones et al., 1993). A study conducted in 
Ethiopia determined that HIV-positive patients with PTB were less likely to have smear-
positive, and HIV-infection patients developed EPTB later than PTB (Yassin et al., 
2004).  A study conducted in Tennessee to ascertain the effect of the AIDS epidemic on 
EPTB determined that the epidemic did not affect the number of cases reported, however, 
EPTB was more frequent in non-white children 0-14 years and the most common forms 
of EPTB were miliary, lymphatic, and meningeal TB (Mehta, Dutt, Harvill, & Mathews, 
1991).     
Extrapulmonary TB is a common phenomenon among HIV-infected and AIDS 
patients; the prevalence increases as HIV progresses to AIDS (Berenguer et al., 1992; 
Shafer, Kim, Weiss, & Quale, 1991).4  However, the specific profile of extrapulmonary 
TB in HIV-infected children is not recognized.  In children four years old and younger, 
TB is typically disseminated into the body through the bloodstream thus increasing the 
risk for tuberculous meningitis. 
 
                                                 
4 Although extrapulmonary TB is stated to be common, no exact rate is published. 
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Study Objectives 
The objectives of this study are two-fold.  The first objective is to describe the 
population of children discharged from Grace Children’s Hospital with a confirmed 
clinical diagnosis of tuberculosis overall, and broken down by whether or not the child 
had an extrapulmonary manifestation of the TB disease.  Specifically, we describe the 
demographic characteristics, and the prevalence of HIV and other co-morbidities of the 
children, in-hospital mortality and the diagnostic tools used to determine TB infection 
including the sputum test, and the documentation of family members also infected.  As 
part of the descriptive process, by examining those with only pulmonary TB (PTB) and 
extrapulmonary TB (EPTB) separately, we investigate if they appear to be different sub-
populations based on demographic characteristics and clinical measures.  The second 
objective of this work is to determine if there is a positive association between HIV 
infection and the EPTB manifestation in children with a confirmed diagnosis of TB, both 
crudely and after adjusting for demographic variables and co-morbidities.   
 
Background and Significance 
Tuberculosis is a very contagious, but curable disease.  The tubercle bacilli 
primarily affect the lungs in approximately 75% of sufferers to give rise to pulmonary 
TB; it can also involve other parts of the body and produces extrapulmonary TB 
(Houghton, 2002).  Extrapulmonary areas typically include the lymph nodes, pleura, 
bones and joints, meninges, genitourinary tract and kidneys (DHPE, 2004; Houghton, 
2002; WedMD Health, 2001).   
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Tuberculosis infection does not unvaryingly result in disease.  Ninety percent of 
immunocompetent persons infected with TB do not develop the disease; although people 
with weakened immune systems are at higher risk of developing TB disease (DHPE, 
2004).  This population includes infants, children, the elderly, and those with 
immunocompromising diseases, particularly HIV infection.  The human 
immunodeficiency virus disease is very complex and its natural history can be further 
complicated by a myriad of factors: mode of transmission, the prevalence of 
opportunistic infections, the availability of anti-HIV therapy, host genetics, and the viral 
strain (Deschamps, Fitzgerald, Pape, & Johnson, 2000).  Infection with HIV causes 
destruction of the cell-mediated immunity in infected patients, which increases 
susceptibility to both pulmonary and extrapulmonary TB.  
Among children, HIV and TB are closely related and the presence of tuberculosis 
in the pediatric population of a given area is used as a measuring instrument to determine 
the prevalence of TB in the adult population (Mwinga, 2005).  Although HIV co-
morbidity is found in more than 50% of pediatric TB cases, children seldom present for a 
primary diagnosis of HIV.  More than 25% of infants born HIV-positive developed TB 
within the first two years of life (Chintu & Zumla, 1995).  At this time, no specific or 
definitive diagnostic tool to diagnose TB in infants and young children exists.  Further, 
these cases may be very difficult to identify due to lack of specificity in signs and 
symptoms and complications in acquiring samples for bacteriologic confirmation 
(American Lung Association, 2003; Chintu & Zumla, 1995; Vallejo, Ong, & Starke, 
1994).   
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Infection with HIV progresses more rapidly to AIDS in children because of the 
inability of the underdeveloped immune system to fight the maturation of the virus.  
According to Bartlett (2004), 20% of children with HIV develop serious and recurrent 
bacterial infections, which include meningitis and pneumonia.  Dependent on the damage 
done by the virus on the immune system, HIV-infected children are prone to develop 
disseminated TB: tuberculous meningitis, miliary TB, and tuberculous lymphadenopathy 
(WHO, 2000a). 
Recent data complied by the UNAIDS estimates the worldwide number of people 
living with HIV to be 37.8 million, among them two million children and 17 million 
women (UNAIDS & HIV/AIDS, 2004).  Global HIV infection has increased in both 
adults and children but this increase has been mostly seen in countries where 
heterosexual intercourse is the most common mode of transmission.  In the Caribbean 
and sub-Saharan Africa, heterosexual intercourse is the primary mode of transmission for 
HIV.  In these countries, the number of women and men infected with HIV and AIDS 
reached a 1:1 ratio in 2002 (UNAIDS, 2004a).  In the Caribbean and Central America, 
the HIV epidemic is focused among heterosexuals, especially commercial sex workers 
who are predominately women.  In contrast, in South America, HIV infection is generally 
characterized by intravenous drug users and men who have sex with men (UNAIDS, 
2004a).   
In Latin America and the Caribbean alone, over two million people are estimated 
to be living with HIV.  In 2003, there were 250,000 new HIV infections in these regions 
with 120,000 AIDS deaths.  In Haiti, 280,000 people are living with HIV, a rate that 
ranks higher than any other country in Latin American or the Caribbean (UNAIDS, 
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2004a; UNAIDS & HIV/AIDS, 2004).5  At the end of 2003, more women than men were 
living with HIV in the Caribbean (UNAIDS, 2004a).6  The following are estimates for the 
year 2003 and the first quarter of 2004, based on published data for the years 1999 and 
2001 and most recent trends from a national surveillance system: the total number of 
people infected with HIV/AIDS in Haiti is 260,000 (range 120,000 - 560,000), and the 
number of children is estimated to be 19,000 (range 7,900 - 45,000) (UNAIDS/WHO, 
2004).7   
 
Country Profile 
Haiti shares the Island of Hispaniola with the Dominican Republic; Haiti is on the 
west and the Dominican Republic is on the east.  Haitians are descendants of mostly West 
African slaves and Europeans.  Two languages are spoken in Haiti: French and Creole; 
the former is the official and the latter the maternal language.8  Haiti is the first black 
republic and the second oldest republic in the New World after the United States.  The 
population of Haiti for the year 2004 is estimated at 8,437,000 with an annual growth rate 
of 3.0; 43% of Haiti’s population is under 14 years old (CIA, 2005).   
Although Haiti is mostly rural, the greater part of its health resources are located 
in the capital city, Port-au-Prince, which constitutes slightly over one-third of the 
population (EarthTrends Country Profiles, 2003).    Its past and present is plagued with 
political upheavals at the hands of its governments.  In the past 18 years, Haiti has 
suffered several political crises and has had a total of 13 governments (UNAIDS, 
                                                 
5 Adults and children (0-49 years). 
6 Ratio of 3:1. 
7 The definition used for adult and children can be simplified as, men and women aged 15 to 49 years for 
the former, and 0 to 15 years for the latter. 
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2004b).9  Since the country does not have a stable economy, it lacks the infrastructure, 
effective manpower, and resources to provide basic care to its people.  
Health care services are not free in Haiti; they are mostly an out-of-pocket 
service.  According to PAHO/WHO, in 2002, Haiti spent no more than one percent of its 
gross domestic product on health expenditures, with only 60% of the population 
benefiting from these services (PAHO, 2003).  Over two-thirds of the country is rural, 
and while there are a total of 371 health posts, 217 health centers, and 49 hospitals, they 
are divided into Haiti’s nine departments.  Forty percent of the population is estimated to 
rely on traditional medicine for health care (PAHO, 2003).  Economic, social, and 
cultural factors heavily influence how and when individuals seek medical care.  With 
over 60% unemployment and under-employment, most people are not able to afford basic 
health care and therefore rely on traditional medicine.   
Tuberculosis is among the many infectious communicable diseases that afflict 
people globally, especially in countries like Haiti.  The World Health Organization 
declared TB an important global health problem in 1991 and devised strategies for its 
control.  In 2002, there were an estimated 370,000 new cases of TB and 53,000 deaths in 
the Americas.    In that same year, Haiti had 12,066 reported TB cases with the highest 
rate of cases in the Americas (147 cases per 100,000 people) (WHO, 2005).   
Since the HIV epidemic began in Haiti in the early 1980s, life expectancy at birth 
has dramatically decreased by six years.  Life expectancy for men is 50.2 years and 56.5 
years for women (EarthTrends Country Profiles, 2003).10  In 2002, the infant mortality 
rate per 1000 live births was 138 deaths for males and 128 deaths for females.  The 
                                                                                                                                                 
8 Creole became official in 1987. 
9 Eighty percent of people in Haiti live in poverty. 
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mortality rate for under-fives for that same year was estimated to be 103.7 per 1000 live 
births (PAHO/WHO, 2003; WHO, 2004).  Since 1997, the cause of death data has been 
collected from hospital death certificates (UNAIDS/WHO, 2004).  The acquired 
immunodeficiency syndrome is the leading cause of death among the adult population 
and is suspected to be the primary cause of death in children in Haiti.  The 2003 data 
indicated the estimated number of adults receiving anti-HIV therapy was 1,370 while the 
estimated number of patients in need of anti-HIV therapy was 40,000 (WHO, 2004). 
The prevalence of HIV in Haiti has neared six percent and is among only three 
other countries in the region with a prevalence rate above three percent (UNAIDS, 
2004a).11  A study conducted at a prenatal clinic in Port-au-Prince indicated that HIV 
prevalence was almost ten percent among pregnant women (DHPE, 2004). In Haiti, as in 
other developing countries, heterosexual intercourse is the most common mode of HIV 
transmission.  Many infected women, unaware of their status, become pregnant and give 
birth to infected babies (Jean et al., 1997; UNAIDS, 2004a). The majority of infected 
children in Haiti acquire HIV through vertical (mother-to-child) transmission.  The 
increase in HIV-infected newborns is believed to have had a direct impact on the nation's 
infant mortality rate (Jean et al., 1997).  However, an accurate measure of HIV infection 
and HIV-related deaths among Haitian children is difficult to determine for two main 
reasons: (1) there is a lack of diagnostic tests for HIV in children; and (2) there are no 
complete definitions in existence for pediatric HIV clinical manifestations (American 
Lung Association, 2003).  Nevertheless, AIDS-related infant mortality in Haiti is 
estimated to be 20% (Jean et al., 1997).   
                                                                                                                                                 
10 2000-2005 projections. 
11 Bahamas and Trinidad & Tobago are the other countries. 
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Historical Perspective and Pathomechanics of TB and HIV/AIDS 
Tuberculosis is an infectious communicable and curable disease caused by the 
tubercle bacillus.  There are three major tubercle bacilli that can cause disease in humans: 
Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avis (Houghton, 
2002).  Tuberculosis existed in animals in the Paleolithic Period (Mycobacterium bovis), 
prior to becoming a threat to humans (Bates & Stead, 1993; Kime, 2002).12   The 
pathogenicity of M. tuberculosis threatens humans, other primates, and guinea pigs, while 
M. bovis is dangerous to many other animal species, most specifically, cattle (Daniel, 
2000). The first human infections are theorized to have occurred through M. bovis during 
the inception of the horticultural period, through the ingestion of contaminated meats 
and/or milk from infected animals.  However, M. bovis is no longer a threat to humans 
since the introduction of pasteurization of milk (Houghton, 2002). 
 Evidence suggests tuberculosis in Europe in the Neolithic Period was common, 
but was largely absent at this time in Asia (Daniel, 2000; Kime, 2002).  According to a 
number of hypotheses (archeological, linguistic, and scientific evidence), the existence of 
mycobacterium in pre-colonial America first occurred 30,000 to 35,000 years ago 
through two major movements of migration from Asia.  However, the type of 
mycobacterium transported to the Americas is still heavily debated.   Although 
mycobacterial DNA was extracted from a 1000 year-old Peruvian mummy by Salo and 
colleagues, the species of mycobacterium was not identifiable (Daniel, 2000).  
Unfavorable climates prevented the preservation of human remains in other locations in 
                                                 
12 M. tuberculosis and M. bovis are two different species, which are closely related genetically; both are 
members of M. tuberculosis complex. 
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the Americas, and as a result, only speculative inference can be made about the existence 
of M. tuberculosis in other settlements (Daniel, 2000).  
While TB devastated the American Indians in North America, evidence shows it 
was not known in sub-Saharan Africa and in certain areas of North Africa.  Furthermore, 
TB was not known in areas of Africa that were not colonized, or in remote villages that 
were isolated from the spread of the tubercle bacillus.  Other studies (Cummins, 1920; 
Hirsch, 1886; Linchenstein, 1928; Livingston, 1857) carried out in that region did not 
find evidence of TB until the first half of the 19th century (Africans were TB-free when 
they were brought to the U.S).  When the Africans became exposed to the disease either 
from the Europeans or Egyptians, they developed the violent form that is sometimes 
referred to as sub-acute TB (the sub-acute typhoidal illness), and experienced a high 
mortality rate.   
Several other studies (Grigg, 1958; McCarthy, 1912; Yandell, 1831) show that 
African Americans are less resistant to TB than are whites.   Investigators found that 
HLA-DR expression by monocytes, which provide innate resistance to TB, are twice as 
common in European Americans as in African Americans (McPeek, Salkowitz, & 
Laufman, 1992).  Another study among 41,000 nursing home residents determined that 
African Americans were less resistant to infection with M. tuberculosis (Bates & Stead, 
1993).   
 
Scientific Discoveries and Anti-TB Therapy 
Hippocrates (460 – 370 BCE), the famed physician of Ancient Greece, referred to 
tuberculosis as phthisis, which is the Greek term for consumption (Basel, 1998; 
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Houghton, 2002).  He was the first to observe tubercles, then called phymata, in animal 
tissues (cattle, sheep, and pigs) (Basel, 1998).  At the time, TB or phthisis was considered 
a hereditary non-infectious disease.  Aristotle was the first to believe that phthisis was 
contagious.  Francastorius of Verona (Girolamo Fracastoro) (1478 – 1553), was the first 
to suggest that phthisis was transmitted by an invisible “virus” and also that the “virus” 
could live on the garments of the infected person for as long as two years. 
Most notably, the evolutionary scientific work on TB over the centuries has 
proven the existence of the disease in many different parts of the world.  Preliminary 
efforts were focused on the identification of the microorganism, then on the containment 
of the disease.  Epidemics of tuberculosis or the “White Plague” caused countless deaths 
over the centuries.13  There were many debates and uncertainties among scientists on the 
mode of transmission, the many forms of TB, its pathogenesis, and etiologic nature.  In 
1834, Johann Lukas Schonlein developed the term 'tuberculosis' to describe affliction 
with tubercles, but he did not recognize the similarity between scrofula and phthisis.14  
In an effort to prove the infectious nature of tuberculosis, in 1840, Jakob Henle 
 presented the following postulates: 
1) The causative agent must be found in every case of a disease; 2) it must not 
occur in another disease; and 3) its application must always provoke the same 
disease (Basel, 1998; Loffler, 1958).   
Jean Antoine Villemin (1865) discovered the disease was caused by a specific 
airborne microorganism.   Then, in 1882, microscopist Robert Koch (who trained under 
Henle), produced irrefutable evidence that tuberculosis was caused by a specific microbe 
                                                 
13 Other referent names for TB disease: scrofula, king’s evil, Pott’s disease, military TB, tabes mesenterica, 
and lupus vulgaris (Houghton, 2002). 
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- Mycobacterium tuberculosis.  He also developed the tuberculin skin test that is still in 
use today in the identification of those who are infected with TB.  Another milestone in 
the history of tuberculosis was the discovery of x-rays by the physicist Wilhelm Conrad 
von Rontgen, in 1895.  X-rays are used to determine severity and to monitor TB (Basel, 
1998). 
Some efforts of the early treatment methods for tuberculosis included the 
promotion of self-healing in sanatoria, and lung collapse therapy (pneumothorax and 
thoracoplastic).  These methods were considered to be applicable to strengthen the human 
body against the tubercle bacilli.  There were different forms of sanatoria and they were 
all situated in elevated locations where those suffering with TB or consumption went to 
seek treatment.  A typical treatment regimen included strict rest cure and sensible diet.  
The pneumothorax therapy was first created by Carlo Forlanini of Pavia, in 1888, and 
consisted of filling the pleural cavity with nitrogen.  Thoracoplastic, an extrapulmonary 
procedure, was another method used and was developed in Germany by Max Schede.  It 
is a surgical procedure of unilateral partial rib resection to reduce the volume of the 
thoracic cavity (Schede, 1890).  Among all the treatment methods listed above, the latter 
was the most effective with only a 20% rate of case-fatality.  Other forms of treatments 
used included many complicated intrapulmonary operations such as lobectomy, 
segmentectomy, and decortication. 
Vaccination against the mycobacterium predates antibacterial treatment regimens.  
The Bacille Calmette-Guerin vaccine (BCG) was developed in 1906 from attenuated 
bovine strain of tuberculosis by Albert Calmette and Camille Guerin (Basel, 1998; 
Houghton, 2002).  It was first administered in France, in 1921, among children who were 
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14 Scrofula is also known as Tuberculous lymphadenitis. 
 
 
at high risk of becoming infected with TB.  Vaccination continued thereafter throughout 
Europe. The most lethal form of TB, miliary, and meningitis were thought to have been 
eliminated among BCG vaccinated children but the benefits of BCG vaccination in adults 
is not considered beneficial (eCureMe, 2003).15  
The development of antibacterial treatments against tuberculosis with low toxicity 
levels was very challenging.  In 1939, Selman Waksman of the University of California, 
successfully isolated an antibiotic (actinomycin), which was very toxic in both human 
and animal (Basel, 1998).  Later, in 1942, he also isolated cultures of another 
streptomycete (streptomyces griseus), which ultimately gave rise to streptomycin.  
Streptomycin was used alone as a successful treatment regimen against TB until scientists 
detected resistance to the drug.  Other antibiotics for TB treatment regimens used in 
combination with streptomycin and their date of discoveries are as follows: p-
aminosalicylic acid (1949), isoniazid (1952), pyrazinamide (1954), cycloserine (1955), 
ethambutol (1962), and rifampin (rifampicin 1963).  Treatments used in situations where 
drug resistance to TB has been developed are referred to as aminoglycosides and 
quilolones.  Aminoglycosides include capreomycin, viomycin, kanamycin, and amikacin.  
Quilolones include ofloxacin and ciprofloxacin (Basel, 1998).   
In recent years, TB among African Americans has followed a different pattern 
than when it was first introduced in that population.16  The presentation of TB in African 
Americans today takes the same chronic form as in European Americans.  This is an 
indication for the selection of TB resistance, which dates back 15 to 20 generations. 
 
                                                 
15 The BCG is used in most developing countries where TB prevalence is high.  It has shown to help reduce 
the risk of the development of tuberculosis (Bates & Stead, 1993). 
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Transmission 
Tuberculosis is transmitted through person-to-person close contact.  The droplet 
nuclei gain entry into the body through contact with a symptomatic individual's bodily 
aspirant.17  Tuberculosis is not transmittable through shaking hands with or touching the 
clothes of the infected person (Houghton, 2002).   
Infants can acquire the tubercle bacilli through aspiration or ingestion of their 
mother’s infected amniotic fluid either before or during pregnancy (eCureMe, 2003).  
Mycobacterium tuberculosis is among the many bacteria that affect AIDS patients, and 
TB is known to accelerate the progression of HIV infection to AIDS (Bartlett, 2004; H. 
Hausler, 2000).  Pulmonary TB occurs in 70 to 90 % of HIV-infected patients; moreover, 
its spreading is related to the patients’ CD4+ T-lymphocyte cells.  Infection with HIV is 
one of the major risk factors for patients to become infected with TB.  Though the 
lifetime risk for the general population or immunocompetent persons to develop TB 
disease after M. tuberculosis infection is only ten percent, TB infection tends to be 
reactivated in HIV-infected patients very early and at a higher rate because of 
immunosuppression (Marques, Rioja, Oliveira, & Santos, 1996).18    
Children with HIV infection are faced with increased frequency of childhood 
diseases such as ear infections and pneumonia.  In addition to the previously mentioned 
illnesses, children in developing countries are further faced with chronic gastroenteritis, 
tuberculosis, and enlargement of the lymph nodes and liver.  The majority of these 
children have neurological implications, which involve infection in the brain and/or 
developmental delay.  Response to standard treatment for infections in HIV-positive 
                                                                                                                                                 
16 It was frequently expressed in extrapulmonary disseminated form.  
17 Sneezing, singing, talking, coughing, and spitting (Board of Health, 2004; Houghton, 2002). 
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children is often not successful and these children often face severe complications that 
are life-threatening (F. Thomas, 2004; WHO, 2000a).   
In HIV-infected persons, the clinical presentation of TB often depends on the 
amount of damage measured by the immune system; the amount of harm the virus has 
done to the person’s CD4+ T-lymphocyte cells.  In patients with HIV infection CD4+ T-
lymphocytes 200 per microliter counts or above, sputum smear examinations for acid-fast 
bacilli (AFB) are often positive for this population.  Patients with CD4+ T-lymphocyte 
counts below 200 are characterized by clinical symptoms including extrapulmonary TB 
diseases (Prasad et al., 2004).  According to Marques (1996), diagnosing TB in AIDS 
patients should be different from that of non-AIDS patients.  Marques (1996) suggests 
blood cultures, biopsy of organs (i.e., the liver), and aspirates of bone marrow and lymph 
nodes.  In addition, in TB endemic areas or where HIV is also endemic or has high 
prevalence, urine, sputum, and blood cultures should be routine tests in AIDS patients 
suspected of having tuberculosis. 
 
Tuberculous Meningitis 
Meningitis is an inflammation of the membranes that cover the brain and spinal 
cord and can be caused by either viruses or bacteria (Board of Health, 2004; IDPH, 2004; 
F. Thomas, 2001).  Analysis of a sample spinal fluid is used to determine which germ has 
infected the patient.  Both viral and bacterial meningitis are contagious and are spread 
through person to person casual contacts (Board of Health, 2004).19, 20, 21 Viral meningitis 
                                                                                                                                                 
18 Each year, HIV-positive persons have a 7% chance increase of developing TB (eCureMe, 2003).  
19 Aseptic meningitis (DHPE, 2004). 
20 Sharing a glass, cup, eating utensils, and respiratory secretions (Board of Health, 2004). 
21 In addition, viral meningitis is said to be transmittable through fecal contamination.  
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is more prevalent, less severe than bacterial meningitis, and has an incubation period of 
three weeks (Board of Health, 2004; Irishhealth, 2004).22, 23  Viral meningitis is most 
frequently caused by enteroviruses that affect the stomach and small intestine.  Others are 
caused by mosquito-borne viruses or arboviruses (IDPH, 2004).24  Conversely, bacterial 
meningitis can be serious, causing brain damage or death, and has an incubation period of 
ten days (IDPH, 2004).25  Furthermore, bacterial meningitis requires the intervention of a 
clinician to determine which type of antibiotics should be administered.   
Meningeal TB infection is very serious in children.  Internationally, bacterial 
meningitis is a major cause of death and disability in children.  A modest annual 
estimation of childhood deaths due to bacterial meningitis is 125,000 (Duke, Curtis, & 
Fuller, 2003; H. Hausler, 2000; Molyneux et al., 2003).26  Studies of HIV-positive 
children with meningitis are limited but the most common cause of meningitis in this 
group is S. pneumonia and H. influenzae.  Meningitis infection in HIV-positive children 
has a higher mortality rate than in HIV-negative children; moreover, it is among the top 
ten killers of children worldwide.  In children with HIV, meningitis is a common cause of 
death, which is further complicated with pneumonia and other forms of bacterial sepsis.  
This often creates additional difficulties, causing chronic failure to thrive, and increases 
the incidence of diarrheal disease.   
                                                 
22 Viral meningitis has no known treatment; it is a mild infection and often clears up in one week or less 
than ten days.  
23 Treatment involves hydration of the patients and reduction of the fever. 
24 At least 80 different types found in fecal excretion of persons infected with viral meningitis. 
25 There are at least 50 types of bacteria that cause meningitis, but there are only two types that are worth 
mentioning: meningococcal and pneumococcal.  The bacteria that cause these two types of meningitis live 
in the upper respiratory tract (throat, nose, sinuses or larynx) (Irishhealth, 2004). 
26 The case-fatality rate of bacterial meningitis is much higher in children in developing countries than in 
children in the developed countries.  
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Patients with HIV infection are at higher risk (than the general population) of 
acquiring the many different types of meningitis, which also include TB meningitis 
associated with HIV infection (Yechoor, Shandera, Rodriguez, & Cate, 1996).  During 
the earlier phase of HIV infection, patients develop what is often referred to as a 
mononucleosis type illness, which is not known to be associated with encephalitis (F. 
Thomas, 2001).27  In pediatrics, TB meningitis most frequently occurs in children aged 
six months to four years.  It progresses much quicker in infants than in young children, 
and experts recommend initiation of treatments for TB meningitis before results of 
required examinations are known (eCureMe, 2003). 
In HIV-positive adults, at least 25% of the meningitis cases are caused by M. 
tuberculosis; 25% are due to acute bacterial meningitis; viral meningitis accounts for 
approximately 15%; and cryptococcal meningitis between 10 to 15% of cases (Duke et 
al., 2003).  Furthermore, S. pneumoniae is often the most common cause of meningitis in 
HIV-positive adults.   
 
Osteomyelitis TB 
The definition of osteomyelitis is an infection of the bone and bone marrow that is 
caused by bacteria, fungi, and AIDS-related opportunistic infections (Gunja, 1997).28  
The infection occurs elsewhere in the body, most frequently in the lungs, but is spread 
throughout via the bloodstream.  This is referred to as haematogenous osteomyelitis.  
Osteomyelitis usually occurs after an open injury where there was contamination of the 
                                                 
27 Usually within days or weeks. 
28 About 60% of all the cases are caused by Staphylococcus aureus.  Others include E. coli, Salmonella, 
Strep. Pneumonia, H. influenzae, Brucella, and tuberculosis bacilli. 
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bone.  Due to extensive blood circulation, children are more prone to becoming infected 
than are adults (Gunja, 1997; Health24, 2003).29  
 
Lymph node TB 
The lymphatic system is attacked by HIV upon entrance in the body.  Typically, 
an HIV-infected person develops the acute retroviral syndrome within one to three weeks 
of infection.30  These symptoms are not specific to HIV but necessary for the replication 
of the virus.  The duration of these symptoms is between one and four weeks.  The 
infected individual becomes asymptomatic thereafter, but is infectious for a period that 
could be ten years or longer before AIDS-related symptoms develop (Bartlett, 2004).  
Tuberculosis lymphadenitis occurs when M. tuberculosis infects the lymph nodes.  It 
causes the lymph nodes to enlarge and form masses in the neck, which may sometimes 
drain in the skin.  Tuberculosis lymphadenitis is the second most common type of TB in 
children (eCureMe, 2003). A study conducted in India found that among 1616 HIV-
positive patients with known CD4+ counts, tuberculous lymphadenitis was present in 
41% (Shobhana et al., 2002).   
In Hochedez et al. (2003), lymph node TB was found to be more common in 
HIV-positive patients.  However, it was also found among HIV-negative patients because 
of immunosuppression.31  The characteristics of the lymph node TB in HIV-infected 
patients were more prominent.  The study was conducted in France among a sample of 32 
patients with lymph node TB: 13 HIV-positive and 19 HIV-negative.32  The median time 
                                                 
29 The lower leg or tibia. 
30 Fever, sore throat, headache, skin rash, tender lymph nodes and malaise. 
31 Intravenous drug use.   
32 The average age of these patients was 36.5 years for HIV-positive and 38.5 non-HIV patients.   
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spent before seeking care after the appearance of signs and symptoms related to lymph 
node TB in the two groups was one month for the non-HIV group and two months for the 
HIV-positive group.  The tuberculin skin test produced a positive reaction in 63% of 
HIV-negative and 15% in the HIV-positive patients.   The manifestation of lymph node 
TB among the HIV-positive patients was more disseminated and affected the abdomen 
more frequently. 
 
In this chapter we discussed the past research and findings of studies on TB 
disease and HIV infection in both adults and children, and the complications of 
diagnosing TB in both HIV-positive and HIV-negative children, with an emphasis on 
resource-poor countries.  In Chapter Two, we provide a global overview of HIV/AIDS 
and tuberculosis and its transmission and diagnosis in children.  Moreover, the basics of 
tuberculin skin tests and BCG examination are discussed.  In Chapter Three, we present 
the research design, study site and population, and statistical methods and data analysis.  
Next, in Chapters Four and Five, we present the results of the investigation and 
discussion of the findings, respectively.   
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CHAPTER II  HIV & AIDS 
The human immunodeficiency virus is the causative agent of AIDS (Rambaut, 
Posada, Crandall, & Holmes, 2004).  Because of lack of accurate data, the determination 
of HIV-1 geographic origin is notional.  Scientific evidence has documented the 
introduction of the HIV epidemic to be of zoonotic sourcing, particularly that of multiple 
species transmission among simian species (Lemey et al., 2003).  Other scientific and 
non-scientific postulates on the origin of HIV have been attributed to some of the 
following: vaccines HIV-contaminated polio, smallpox, hepatitis and tetanus; the African 
green monkeys; African people, their cattle, pigs, and sheep; and the CIA (Lemey et al., 
2003; Stine, 2003).   
HIV-1 like symptoms or AIDS-related opportunistic infections (OIs) were first 
discovered among gay men in Los Angeles, California, in 1981; chronological data 
suggest symptoms seen among gay men in the U.S. were discovered among previously 
healthy Haitian men in Haiti in 1979 (CDC, 1998b).  The French physician Luc 
Montagnier, co-discoverer of HIV, first heard of the "gay disease" in 1982 after Robert 
Gallo, of the United States, found the retrovirus that caused AIDS in patients in Los 
Angeles.  At the time, there were only a small number of patients in France with the 
disease in question (Montagnier, 2002).  Then, the retroviruses were known as the human 
T cell leukemia viruses, HTLV-1 and HTLV-2, and the process of identifying the virus in 
the blood was identical to that of today (Montagnier, 2002).  In 1984, the collaborative 
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efforts of two groups of scientists, led by Luc Montagnier and Robert Gallo, discovered 
that HIV causes AIDS. 
The chronology of the first few global AIDS cases is as follows: in 1959, 
scientists found evidence of HIV in blood samples collected from a patient in a malaria 
endemic town in Kinshasa, Zaire; the individual later died of AIDS. Evidence of HIV 
antibodies was found in a frozen sample of a 15 year-old male prostitute with the 
manifestation of Kaposi’s sarcoma who died in 1969 (Stine, 2003).  In 1976, a Danish 
surgeon who had worked in Zaire died of an AIDS-related illness.  Another AIDS case 
with highly controversial results was presented in 1999 at the 11th International Congress 
of Virology.  
 
Transmission and Diagnosis of TB and HIV in Children 
HIV Transmission in Children 
Vertical transmission is the most common mode of HIV transmission in children.  
The neonate can become exposed to maternal infected birth fluid during the birthing 
process; furthermore, post-partum HIV infection poses a 30% risk of transmission in 
infants through breast milk (WHO, 2000b).  Other sources of HIV infection in infants and 
children include sexual abuse, transfusion with HIV-contaminated needles, blood or 
blood products, and child prostitution (WHO, 2000b).  Research has not yet shown the 
determinant stage in which HIV infection occurs (in utero, during delivery, or 
postpartum), moreover, it is difficult to pinpoint the exact stage the virus starts depleting 
the immune system (F. Thomas, 2004).    
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Diagnosing HIV in Infants, Children, and Adolescents 
There is great similarity in childhood related illness regardless of HIV status.  In 
general, most of the pathogens that cause illness in children also cause illness in HIV-
positive children but at a higher rate.33   Though both HIV-positive and HIV-negative 
children are often affected by similar pathogens, there are some illnesses that occur more 
frequently in HIV-positive children than in their HIV-negative counterparts (WHO, 
2000a).   
The presentation of HIV-related infections in children varies.  Some HIV-infected 
children develop severe clinical signs and symptoms very early after becoming infected 
with the virus, some may develop signs and symptoms within a year, while others can 
remain asymptomatic until teenage years.34  According to WHO (2004), healthcare 
providers are to suspect HIV in infants or children who have recurring infections of 
pneumonia, meningitis, sepsis, and cellulitis in a period of 12 months; the presence of 
oral thrush that lasts more than one month after the neonatal period; chronic parotitis 
either with or without pain or fever for more than 14 days; generalized lymphadenopathy; 
the presence of hepatospenomegaly without any viral infections (i.e., cytomegalovirus); 
the persistence of or recurrent fever that lasts more than 7 days; neurological dysfunction; 
HIV dermatitis; and herpes zoster (shingles).35  Further, there are signs and conditions 
that are specific to children with HIV: pneumocystic carinii pneumonia (PCP), 
                                                 
33 e.g., pneumococcal infections and pulmonary tuberculosis. 
34 During their first year of life. 
35 Progressive neurological impairment, microcephaly, delay in achieving developmental milestones, 
hypertonia, or mental confusion. 
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oesophageal candidiasis, lymphoid interstitial pneumonia (LIP), and shingles across 
several dermatomes or Kaposi sarcoma.36  
In settings where resources are limited or where testing for HIV in children is 
unavailable, diagnosing AIDS in children is done through observation for at least two 
major and two minor signs.  The major signs include: weight loss or abnormal slow 
growth; chronic diarrhea for more than one month; and prolonged fever for more than 
one month.  The minor signs are: generalized lymph nodes enlargement; recurrent 
common infections of the mouth and/or throat; persistent cough; generalized rash; 
confirmed HIV infection in the mother; and fungal infections.37  The following criteria 
are used to diagnose HIV in infants, children, and adolescents:  
1. Diagnosis: HIV-infected 
 
a) A child less than 18 months of age who is known to be HIV seropositive or 
born to an HIV-infected mother and: i) has positive results on two separate 
determinations (excluding cord blood) from one or more of the following HIV 
detection tests: HIV culture, HIV-DNA-PCR or HIV-P24 antigen; ii) meets 
criteria for AIDS diagnosis based on the 1987 AIDS surveillance definition. 
 
b) A child 18 months of age born to an HIV-infected mother or any child 
infected by blood, blood products, or other known modes of transmission (e.g. 
sexual contact) who: i) is HIV-antibody positive by repeated reactive EIA and 
confirmatory test; or ii) meets any of the criteria in one of the previously 
mentioned.38  
 
 
2. Diagnosis: perinatally exposed 
 
a) A child who does not meet the criteria above who: i) is HIV seronegative 
by EIA confirmatory test (WB or IFA) and is <18 months of age at the time of 
the test; or ii) had unknown antibody status, but was born to a mother known 
to be infected with HIV. 
 
3. Diagnosis: seroreverter (SR) 
                                                 
36 Common in infants aged six months or younger. 
37 Ear and throat. 
38 Western blot or immunofluorescent assay. 
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a) A child who is born of an HIV-infected mother and who: i) has been 
documented as HIV-antibody negative;39 and ii) has had no other laboratory 
evidence of infection;40 and iii) has not had an AIDS-defining condition. 
 
4. Criteria for HIV infection for persons >13 years: 
 
a) Repeat reactive screening test for HIV antibody with specific antibody 
identified by the use of supplemental test (e.g. WB, IFA);41 i) direct 
identification of the virus in the host tissues by virus isolation; ii) HIV antigen 
detection; iii) a positive result on any other highly specific licensed test for 
HIV (Foshee, 2004). 
 
Diagnosing TB in Infants, Children, and Adolescents 
Tuberculosis diagnosis in the adult HIV-positive patient is more straightforward 
than the child, secondary to the clinical presentation of adult TB.42, 43 Misdiagnosis and 
over-diagnosis of TB disease is common in children due to the fact that some patients are 
asymptomatic or some of the symptoms are nonspecific.  In resource poor settings, 
diagnosing TB in children employs a combination of clinical and epidemiological 
methods, but the diagnosis relies heavily on clinical suspicion (Chintu & Zumla, 1995; 
eCureMe, 2003; Salazar et al., 2001).44  Because of their immature immune systems, 
children who are infected with TB are more likely to progress to TB disease.  
Tuberculosis infection in children usually indicates recent exposure rather than the 
reactivation of latent TB.   While children are at increased risk of developing TB disease, 
most signs and symptoms of tuberculosis are not obvious.  Most often, two main 
                                                 
39 Two or more negative EIA tests performed at 6-18 months of age or one negative EIA test after 18 
months of age. 
40 Has not had two positive viral detection tests, if performed. 
41 Enzyme Immunoassay. 
42 For instance, a typical case might include an individual who does not produce sputum, or when sputum is 
produced, it is more likely not to contain a large quantity of the mycobacterium, sputum cultures are often 
negative, chest x-rays may appear atypical and the patient is more likely to manifest extrapulmonary TB. 
43 Particularly infants. 
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diagnostic tools are important: AFB smears and cultures.45  A spinal tap is recommended 
as in inclusion for meningeal TB diagnosis.   
 
The Basics on Tuberculin Skin Tests and BCG Immunization 
There are three types of tuberculin skin tests: Mantoux, Monotest, and TINE test.  
These tests are used to measure the body’s immune response to the purified protein 
derivative (PPD) injection.  The Mantoux test is an intradermal injection of PPD.46 
TINE/MONO tests are instruments that are impregnated with PPD, and these are pressed 
into the skin of the forearm.  The reaction of the Mantoux and Mono tests are measured 
between 48 and 72 hours and results are recorded in millimeters.  Using a similar time 
interval, the TINE test results are measured based on the amount of blistering on the skin.   
Results of tuberculin skin tests are dependent on several factors, which include 
exposure to TB, contact case, HIV status, country of origin, BCG vaccine, and lifestyle.47  
A positive test indicates TB infection, not disease.  Conversely, a negative skin test does 
not eliminate TB disease.  A TB skin test may be negative yet the disease may still be 
present if the individual has HIV infection, malnutrition, severe viral infections, severe 
disseminated TB, cancer, and use of immunosuppressive drugs.   
The Bacille Calmette Guerin immunization (BCG) is given at birth to children 
born in hospital.  Now, this practice is strictly limited to developing countries.  In 2001, 
the immunization rate for children under one year in Haiti was 49% (PAHO, 2001).  
Immunization with BCG may cause a positive reaction tuberculin test several years after 
                                                                                                                                                 
44 The vagueness in symptoms is common with TB; some of these symptoms include, weigh loss, night 
sweats, fatigue, loss of appetite, and low-grade fever. 
45 Help determine which drugs will work against the organism. 
46 Into, not below, the skin. 
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the vaccination, but this reaction is often weaker and is referred to as a natural infection 
with M. Tuberculosis (H. Hausler, 2000).  In diagnosing TB in children with HIV 
infection, the interpretation of the tuberculin test is even more difficult and should be 
followed by radiographic analysis and other applicable examinations.48  
 
 
                                                                                                                                                 
47 IDU, homelessness, alcoholism and malnutrition. 
48 Follow recommendations for the necessary extrapulmonary TB.  
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CHAPTER III  METHODS 
Research Design 
This is a retrospective chart review of all children aged 14 and younger with TB 
disease admitted to Grace Children’s Hospital.  There are two objectives: (1) describe the 
cases in terms of clinical measures and demographic characteristics; and (2) use a cross-
sectional design to analyze the data.   
 
Study Population 
The data set for this exploratory study is based on a chart abstraction form 
developed in accordance with medical chart forms the investigator obtained from the 
hospital on a previous trip.  At GCH, all children hospitalized for TB disease are screened 
for HIV, except in August of 2002 and the year of 2003, when, due to lack of funding, 
only suspected HIV cases were tested.  Inclusion criteria include all confirmed 
hospitalized pediatric TB cases aged 14 years and younger between January 1, 1999 and 
December 31, 2003, and were reviewed and separated by outcome status: extrapulmonary 
TB and non-extrapulmonary TB.   
The previously stated five-year period was arbitrarily chosen with no preliminary 
pilot study done.  Pregnant teens, prior treatment and hospitalization for TB, and Haitian 
children born in the U.S. were excluded.  Pregnant teens were excluded because we 
wanted to minimize the possibility of including children who may have acquired HIV 
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infection through sexual contact; children with prior hospitalization and treatment for TB 
were excluded to minimize the potential bias of MDR-TB because GCH does not do 
drug-susceptibility testing; and Haitian children who were born in the U.S. were excluded 
because they may have a better health profile (e.g., access to primary health care, better 
nutrition) than the average child hospitalized at GCH.  
 
Study Site 
This study was conducted at the Grace Children’s Hospital (GCH), a referral 
pediatric TB hospital and the only pediatric TB hospital in Haiti.  GCH was founded by 
Jim and Virginia Snarley in 1967.  The hospital is financed and operated by a Christian 
service organization, the International Child Care.  It has been in operation for 37 years 
and provides additional services, especially primary health care, general pediatric clinic 
services, eye care to adults and children, adult TB treatment, reproductive health services, 
and HIV/AIDS counseling and testing to the community.  In August of 2004, GCH added 
antiretroviral therapy to its list of services.  Grace Children’s Hospital oversees the 
majority of TB cases in Haiti and operates mostly on an outpatient system; it is the only 
tertiary pediatric hospital that dedicates over 80% of its facility to treat urgent pediatric 
TB cases and other various diseases.49     
 
                                                 
49 Malnutrition, severe diarrhea, and upper respiratory infections. 
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Statistical Methods and Data Analysis 
Objective 1: Descriptive Study 
To assess if there is a relative association between the manifestation of EPTB and 
HIV infection in children hospitalized for TB treatment, variables will include clinical 
measures and demographics characteristics.  The available sample size of 615 pediatric 
TB cases included 492 PTB and 210 EPTB.  Data collection was based on a chart 
abstraction form developed with information compiled from the hospital on a previous 
visit by the principal investigator.  Age groups were created to measure the number of 
cases per group, EPTB types, and HIV status including those patients who were not 
tested, gender, mortality data, co-morbidity, nutrition status, TB contact, BGC 
vaccination, and bacteriologic examinations (Table 1).  The co-morbidities at time of TB 
diagnosis included anemia, gastroenteritis, intestinal parasite, malaria, sickle cell anemia, 
typhoid, and meningitis.  The nutrition status had two levels: under-five and older 
children.  The under-five group had degrees of undernourishment.  TB contact included, 
mother, father, grandmother, a deceased parent (mother or father), neighbor and other 
relatives (cousin, aunt, brother, sister and/or uncle).  We created a variable called 
Tbgroup, which included both PTB and EPTB; all the necessary information was 
recorded based on TBgroup status (Table 2). 
 
Objective 2:  HIV and EPTB manifestation in TB-infected children 
  Statistical analysis was conducted using SAS statistical software package version 
9.1.  Logistic regression procedure was used to compute the univariate and multivariate 
analyses.  The variables included were TBgroup (PTB vs. EPTB), gender, age, HIV 
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status, nutrition status, and only co-morbidities that were greater than 5% (anemia, 
intestinal parasite, and malaria).  Descriptive statistical measurements were done on the 
following variables: age, gender, patient weight, nutrition status, immunization for the 
BCG vaccine, TB contact, sputum culture examination, co-morbidities, and mortality.50, 
  51 In the univariate portion of the analysis, we determined the probability of patients with 
pulmonary TB on the basis of age, gender, HIV status, nutrition, anemia, malaria, and 
intestinal parasite.  Adjusted values for EPTB were obtained for the following: age, 
gender, and nutrition status. Though both are valid in measuring the level of association, 
Chi-square rather than odds ratio measures was preferred for this study to indicate 
statistical significance.  The default alpha (α = 0.05) was used for Chi-square and p-value.  
                                                 
50 Children under-five are assigned degrees of malnutrition (primary, secondary, and tertiary), marasmus, 
and kwashiorkor; older children do not have degrees of malnutrition, they are reported as either 
malnourished or normal. 
51 Anemia, malaria, intestinal parasites, gastroenteritis, typhoid, sickle cell anemia and a combination of 
two, three or four of the previously mentioned conditions. 
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CHAPTER IV  RESULTS 
Objective 1: Descriptive Results 
 This study sought to describe the demographics of children with pulmonary TB 
(PTB) and extrapulmonary TB (EPTB) in a pediatric TB hospital in Haiti. Data for 615 
hospitalized, confirmed pediatric TB patients were collected for a five-year period from 
January 1, 1999 to December 31, 2003.  These included 492 cases with only pulmonary 
TB and 210 whose TB infection had progressed to extrapulmonary (EPTB).   Eighty-
eight of the extrapulmonary cases also had a concurrent diagnosis of pulmonary TB.  The 
most common sites of EPTB included lymph node, pleura, bone and joint, and peritoneal 
(Table 1).   
There were 315 (51.4%) males and 298 (48.6%) females with a mean age of 5.40 
years (range 0.17 - 14 years), with 214 (37.9%) of the patients aged 0-2 years.52  One 
hundred and seven (17.4%) patients were HIV-positive.  Three hundred eighty-eight 
(63%) patients had one or more additional co-morbidities.  These included anemia 299 
(48.6%), intestinal parasites 93 (15.1%), malaria 58 (9.4%) and gastroenteritis 19 (3.1%).  
Nearly 85% of the children were undernourished.  Eighty-three patients, 13.5 percent of 
the children, died in the hospital. 
Four hundred-eighteen (68.0%) of the patients lived in the major metropolitan 
area.53  BCG vaccination status of 294 (59%) patients was reported, and BCG vaccination 
                                                 
52 Two of the records reviewed did not have documentation of patients’ gender. 
53 One hundred-two (16.5%) of the residential data were missing. 
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percentage for both the under-five and older than five years population was 151(51.5%) 
and 143 (48.6%), respectively. Two hundred fifty-five (48.3%) of the total population 
had a positive PPD with 5 (1%) of that population having a PPD reaction that is referred 
to as phlyctenulaire.54
Two hundred fifty-two (41%) of the patients had a contact source for TB [65 
(25.8%) had a mother who was an active TB case, 25 (10%) had a father who was an 
active TB case, 61 (24.3%) had at least one relative with active TB (i.e., uncle, aunt, and 
cousin), 50 (19.8%) had a neighbor with TB, and 31(12.3%) had parent who died of TB 
disease (mother/father)] (Table 1).  One hundred-twenty (19.5%) of the AFB sputum 
examination data were missing, however, AFB sputum culture was positive for 79 (16%) 
and the tubercle bacilli was detected in 483 (97.6%).   Sputum smear data are not 
considered reliable because they were found on different parts of the charts.  In other 
words, it was very difficult to determine if the tests were requested or done. 
 
Objective 2: Association of HIV with EPTB manifestation in TB-infected children 
Tables 2 through 4 highlight differences between children with localized 
pulmonary TB and children whose TB had progressed to extrapulmonary locations. 
Percent males were 47.8% and 57.9% in PTB and EPTB groups respectively (p<0.05, 
Table 2).  Children with EPTB were much more likely to be over the age of two (74% vs. 
56% in PTB group), resulting in a highly significant Chi-square statistic.  The overall 
difference in mean age, however, was only borderline significant with children with 
                                                 
54 It is an inflammation of the injection site that may contain pus or other types of fluid; this reaction occurs 
as a result of the Mantoux test. 
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EPTB being slightly older [p=0.059] and age was only weakly associated with TB group. 
(Tables 3, 4).    
Children in the EPTB group were somewhat less likely to die in the hospital 
(10.0% vs. 15.4%, p=0.066).  They were much less likely to be HIV-positive (8.6% vs. 
22%, p<0.01).  Seventy-seven (12.5%) of the patients’ HIV status were unknown.  The 
proportion of patients with unknown HIV status in both PTB and EPTB were equivalent, 
50 (12.4%) and 26 (12.4%) respectively.  Although HIV-negative co-morbidities were 
not found to be significant at any level, patients with EPTB also had a lower proportion 
of anemia, malaria, sickle cell anemia, and typhoid than did PTB patients (Table 2).   
Patient body weights were recorded in kilograms.  The mean weight for 450 
patients was 20.16 kg [range 1.00 – 56.50]; however, 165 (26.8%) of patients’ weight 
data are missing.  The percentage of undernourished children in the EPTB and PTB 
groups were 74.4% and 86.6% [p<0.01]. In those under-five for whom the degree of 
undernourishment was recorded, the degree of undernourishment was significantly less 
severe for the EPTB group [p<0.0006] (Table 2).  
Following multivariate adjustments, the negative association between EPTB and 
HIV status remained statistically significant as well as the negative association between 
EPTB and malnutrition; gender was still borderline significant [p=0.062] (Table 4).   
Table 5 combined the two groups and assessed risk factors for mortality in the 
sample.  The OR was greater than 4 for HIV and was greater than 2 for poor nutrition 
status [p<0.01 for each].  There was no association in this model between EPTB and 
mortality.   The apparent univariate association between EPTB and reduced mortality can 
be explained by lower prevalence of HIV and poor nutrition status in the sample.  
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CHAPTER V  DISCUSSION 
Objective 1: Descriptive results 
 The initial research question to determine if there would be a positive association 
between extrapulmonary TB (EPTB) and HIV infection in the children hospitalized at 
Grace Children’s Hospital was not borne out by the reviewed data.  Instead, we had the 
surprising results that among TB-infected children, children with EPTB were less likely 
to be HIV-positive than children without EPTB.   Over 50% of the EPTB compared to 
48% of the PTB cases were males.  Contrary to adult studies, EPTB rather than PTB was 
found to be associated with being female, non-Hispanic black, and HIV-positive (Antony, 
Harrell, Christie, Adams, & Rumley, 1995; Yang et al., 2004).   
In terms of undernourishment, co-morbidities and HIV-infection, PTB patients 
were sicker than the EPTB patients (Table 2).  There are two possible explanations for 
this finding: the potential for misclassification or diagnosis bias (e.g., differential 
diagnostic practices for HIV-positive children that may be related to lack of laboratory 
resources), and the natural history of TB disease.  The diagnosis of TB at the Grace 
Children’s Hospital is based on its basic examination for TB (e.g., clinical signs and 
symptoms, PPD, chest radiograph, sputum tests for older children, and contact case 
investigation), but relies on two principle factors: clinical signs and symptoms, and TB 
contact case.  The physicians often do not rely on chest radiographs because they are not 
considered to be reliable in diagnosing many types of EPTB and are sometimes 
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impossible to acquire (i.e., cost, problems with the hospital’s machine or political unrest 
that often causes businesses to close).  Bacteriologic examination is necessary to 
diagnose EPTB.   
When it comes to children with HIV infection, the potential for diagnosis bias, 
especially differential diagnostic practices, is suspected to be involved.  In these HIV-
positive children, physicians may be less likely to request laboratory examination to 
confirm TB diagnosis, but are more likely to request these examinations for HIV-
negative children. 
While HIV-positive patients were two to three times more likely to have not had 
sputum culture documentation on their medical records, the total number of patients with 
PTB without a sputum culture was 88 (21.8%).  To verify this fact, we excluded the PTB 
patients with negative sputum culture and created two sets of contingency tables.55  We 
first focused on the PTB patients with positive sputum culture and all the patients with 
EPTB to calculate the odds ratio.  Though this caused a decrease in the number of PTB 
patients with HIV-infection, the negative association between EPTB and HIV-infection 
observed was even weaker (OR = 0.89 vs. 0.431).  Then, when we combined the PTB 
patients with sputum culture positive with the PTB patients without sputum culture 
documentation, and included all the EPTB patients, we determined that the association 
between EPTB and HIV-infection increased (OR= 0.26 vs. 0.431). 
 Among the HIV-infected patients with PTB, 50 (56.2%) had a negative sputum 
culture, but were treated for TB disease. With more than 50% of the patients with 
negative sputum culture, it is suspected these patients could have had some other HIV 
                                                 
55 Sputum culture is not necessary for the diagnosis of EPTB. 
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disease associated pneumonia (e.g., lymphoid interstitial pneumonia), and that their 
disease was not at all TB-related.   
 Tuberculosis is very difficult to diagnose in children with HIV as it is seldom 
confirmed by culture. This may sometimes lead to over-diagnosis of PTB or could also 
be mistaken for other HIV-related opportunistic infections.  In a study investigating the 
outcome of tuberculosis in children with AIDS in a culture positive sample, the study 
found that 25% of the patients had lymphocytic interstitial pneumonia (LIP), and 42% 
had pneumonia.  It is documented that both adult and pediatric AIDS patients have 
chronic lung diseases together with atypical x-rays presentation, which may often lead to 
a misdiagnosis of tuberculosis (Chan et al., 1996).   
In another pediatric study of 14 HIV patients with culture confirmed TB, five of 
these patients were found to have EPTB in conjunction with PTB involvement with two 
children with central nervous system TB.  Four of the patients had positive culture for M. 
tuberculosis between 4 to 10 months after the initial diagnosis of TB; three of these 
patients were found to have drug-resistance to TB, and the fourth patient had a source 
case with TB drug-resistance (Schaaf, Geldenduys, Gie, & Cotton, 1998).  Furthermore, 
BCG vaccination data was reported for nearly 60% of the patients with 52% of the 
reported data being in the under-five population.  It is reported that BCG vaccinated 
children with compromised immune systems (e.g., most of our population) are known to 
develop local reactions and disseminated disease (Khouri, Mastrucci, Hutto, Mitchell, & 
Scott, 1992).   
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Objective 2: Association of HIV with EPTB manifestation in TB-infected Children 
 In all TB cases, the lungs are the portal of entry for the bacilli. The natural history 
of TB in children is very complex because many of the clinical manifestations are non-
specific to TB infection or disease.  Children aged 3 years and younger are more 
susceptible to TB and are more likely to develop EPTB (W. Hausler & Sussman, 1998). 
Because of immature immune systems, children are more vulnerable to becoming 
infected through an adult (sputum smear-positive) with active TB disease (Coberly & 
Chaisson, 2001).  In our study, children with EPTB were more likely to be over the age 
of two (74% vs. 56% in PTB group). The overall difference was only slightly significant 
with children with EPTB being slightly older [p=0.059] and age only weakly associated 
with TB group (Table 3, 4). 
The prevalence of HIV in Haiti neared six percent, and although TB is endemic in 
the population, there is no published statistical measurement of pediatric TB in that 
population.56   Jacobs (1997) states that HIV infection in the adult population has a direct 
effect on TB infection and disease in children.  In other words, TB disease in young 
children is used as a measurement of TB in the general population in an area (H. Hausler, 
2000).  Forty-one percent of the children had a TB contact source with 50% having a 
parent or close family member as their contact, and over 12% lost a parent to TB disease 
(Table 1).  
 This study shows that among all the TB cases admitted at GCH between 1999 and 
2003, patients with EPTB were less likely to die in the hospital (10.0% vs. 15.4%, 
p=0.066) and much less likely to be HIV-positive (8.6% vs. 22.0%, p<0.01).  Although 
12.5% of the patients were not tested for HIV infection, the proportion of non-tested 
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patients for both groups was equivalent in both PTB and EPTB (table 2). In other words, 
regardless of age, patients with HIV were more likely to have pulmonary rather than 
EPTB.  While co-morbidities among the HIV-negatives did not prove to be significant at 
any level (anemia, malaria, intestinal parasite, gastroenteritis, sickle cell anemia, and 
typhoid), patients with EPTB had lower proportion of co-morbidities.  
Patients with EPTB had a better risk profile than did PTB patients.  Patients with 
EPTB were more likely to survive.  Extrapulmonary TB patients seen at GCH may have 
been those who survived the disease while others with EPTB compounded by HIV-
infection died prior to coming to the hospital.  In other words, the observed cases can be 
said to be a selected number of children with fewer number of those with HIV-infection.   
Moreover, the children with EPTB were less likely to have nutritional deficiencies; this 
also supports the fact that they would have died if they were malnourished in addition to 
HIV infection and EPTB.   
A study conducted in New York City found EPTB was more common among 
HIV-positive rather than the HIV-negative cases reviewed (38% vs. 13%) (P. Thomas et 
al., 2000).  In this case, the conclusion drawn from these data are correct, which is, 
children with EPTB seen at GCH are probably a false representation of pediatric EPTB 
and HIV-infection in Haiti.  Based on these results, this study is not an accurate 
representation of pediatric EPTB in Haiti.   
Grace Children’s Hospital is a tertiary referral hospital that is often the last 
facility patients are referred to for TB treatment.  This means, by the time these patients 
arrived at this hospital, they had already been to many other centers, clinics, and other 
hospitals, and that their cases had already advanced to the critical stage of TB disease.  
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Potential biases involved are referral, detection, and selection biases.  Patients were 
referred to GCH by other institutions based on treatment failure and lack of accurate 
diagnosis.  During a 10-month period, GCH lacked the resources to test all patients for 
HIV, and therefore, those tested were based on clinical suspicion.  Children with HIV-
infection were less likely to have had laboratory confirmation for TB disease (Table 6).   
As is the case in many resource-poor settings, diagnosing pediatric TB is difficult 
and it is often primarily focused on clinical signs and symptoms, and TB contact case 
investigation.  In addition to the potential for misclassification or diagnosis bias and 
natural history of TB, the divergent findings can further be explained by the fact that 
GCH physicians lack some of the basic diagnostic tools in diagnosing EPTB. Since both 
types of TB are treated with similar antibiotics, physicians may treat patients regardless 
of which types of TB disease they present.  In other words, there may be an under-
reporting of EPTB cases in patients with HIV infection since the treatment regimen for 
both PTB and EPTB is similar (except in cases of miliary TB, bone and joint TB, or TB 
meningitis where the length of treatment is longer).   
Haiti is an impoverished nation plagued by political violence and lacks the 
resources and infrastructure to provide adequate primary and basic healthcare to the 
majority of its citizens.  It is estimated that 40% of the population uses traditional 
medicine not by choice, but because it is the only option open to them.  These treatments 
may last from several weeks to months, and only when progress in their treatment fails, 
patients may seek care from the local health center, which may be located far from their 
homes.57   
                                                 
57 Rate for 2002 was 147 cases per 100,000 persons. 
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Many obstacles may keep patients from acquiring the necessary healthcare, such 
as cost, sporadic political violence, and transportation.  Transportation is a major issue, 
not only due to cost, but also because merely 13% of the roads in Haiti are covered with 
asphalt and accessible for public buses (CDC, 2004).  In rural Haiti, most people have to 
walk for hours before boarding public buses.  Once they arrive at the local health center, 
tests may be requested based on clinical presentation and history.  The individual is 
provided with a prescription to fill or may possibly be referred to the regional hospital.  
In the case of tuberculosis, GCH is the only pediatric TB hospital in the country serving 
all Haiti’s nine departments.  According to information in the medical charts and the 
physicians at GCH, it is the teaching hospital, L’Hôpital Universite d’Etat d’Haiti 
(HUEH) that often referred parents to GCH after they were referred to the general 
hospital by other facilities.  
 Some of the limitations of this study include a significant amount of missing data 
(e.g., age, HIV status, sputum culture), and records for sputum smear were not 
consistently reported in one area of the charts and therefore were not usable because we 
could not differentiate between requesting the specimen examination and test performed.  
CD4+ cell counts and viral loads data were not reported, thus patients with HIV-infection 
could not be differentiated from those with AIDS.  Based on previous studies, it was 
assumed that the patients contracted HIV from their mothers, because there was no record 
on route of transmission.    
According to the Centers for Disease Control and Prevention, 90% of pediatric 
HIV infection occurs through perinatal (vertical) transmission (CDC, 1998a).  Haiti has a 
high illiteracy rate (48%) and over 80% of the population lives in poverty.  Its people 
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suffer from some of the most curable disease.  Our recommendation is for policy-makers, 
non-governmental agencies, and both international and national charitable organizations 
to work with churches and grassroots organizations to institute TB and HIV screenings. 
Further, it is necessary to provide training to these local facilities to help 
communities in identifying the common symptoms of TB disease and refer these 
individuals to a healthcare facility for treatment.  There is a stigma attached to both TB 
and HIV in Haiti, which plays a direct role in delaying medical attention.  TB and HIV 
screening and education should be part of pre-natal care, so that pregnant women can be 
treated and educated on identifying signs and symptoms of both diseases.   
Tuberculosis and HIV are both prevalent in Haiti. The task of combating both 
infectious diseases will involve the concerted efforts of all parties. This includes 
allocation of necessary resources, updated information so that health care providers can 
be knowledgeable on both TB and HIV to minimize misdiagnosis, and ultimately, 
patients need to seek care much earlier in the disease process.  
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TABLES 
 
Table 1: Descriptive Statistics    N= 615 
  n(%) 
Gender (% Males) 315(51.4)
    
Age Group   
0-2 years 214(37.9)
3-5 years 103(18.2)
6-8 years 87(15.3) 
9-11 years 78(13.8) 
12-14 years 83(14.7) 
Age not recorded in chart 50(8.1) 
Mean Age 5.4
    
HIV Status   
HIV+ 107(17.4)
HIV- 431(70.1)
Not Tested 77(12.5) 
    
Pulmonary TB 492(80.0)
  
Extrapulmonary TB 210(34.2)
 EPTB Types   
Bone and Joint 21 
Intestinal 1 
Lymph node 62 
Miliary 4 
Meningitis 6 
Pericarditis 1 
Peritonitis 12 
Pleurisy 35 
Pleuropulmonary  51 
Skin 1 
Lymph node and Peritonitis 4 
Lymph node and Pleurisy 4 
Lymph node and Bone & Joint 2 
Lymph node and Meningitis 1 
Lymph node and Skin 1 
Peritonitis and Pericarditis 1 
Peritonitis and Pleuropulmonary 3 
Pleurisy and Pericarditis  1 
Percent Died 83(13.5) 
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Co-morbidity 
Anemia 299(48.6)
Gastroenteritis 19(3.1) 
Intestinal Parasite 93(15.1) 
Malaria 58(9.4) 
Meningitis 1(0.16) 
Sickle Cell Anemia 13(2.1) 
Typhoid 5(0.81) 
    
Nutrition Status 
All Children   
Normal 96(15.6) 
Undernourished 518(84.4)
Under-5    
Normal  35(11.2) 
Undernourished: primary 69(22.0) 
Undernourished: secondary 96(30.7) 
Undernourished: tertiary 79(25.2) 
Undernourished degree unknown 16(5.1) 
Marasmus 11(3.5) 
Kwashiorkor 7(2.2) 
TB Contact Case 
No TB Contact 103(16.7)
Contact unknown 260(42.3)
TB Contact 252(41) 
Mother 65(25.8) 
Father 25(10) 
Deceased Mother/Father 31(12.3) 
Grandmother 29(11.5) 
Neighbor 50(19.8) 
Other Relatives 61(24.2) 
Sputum Culture 
Sputum Culture (+) 79(12.8) 
Sputum Culture (-) 416(67.6)
Culture not done 120(19.5)
§ Percentages of characteristics are based on non-missing values 
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 Table 2: Pulmonary and Extrapulmonary Tuberculosis 
  PTB EPTB     
  n(%) n(%) 
Chi 
Square p-value 
Gender (% Male) 193(47.8) 121(57.9) 5.5131 0.0189 
          
Age Group     25.3586 <0.0001 
0-2 years 165(43.9) 49(25.9)     
3-5 years 51(13.6) 52(27.5)     
6-8 years 56(14.9) 31(16.4)     
9-11 years 53(14.1) 25(13.2)     
12-14 years 51(13.6) 32(16.9)     
          
Mean age 5.16 5.84     
          
Sputum Culture not done 88(21.8) 32(15.2) 17.7739 0.0001 
  
Percent Died 62(15.4) 21(10.0) 3.3786 0.066 
HIV Status      17.9242 0.0001 
HIV+ 89(22.0) 18(8.6)     
HIV- 265(65.6) 166(79.1)     
Not Tested 50(12.4) 26(12.4)     
          
Co-morbidity N= 388 
Anemia 206(51.0) 92(43.8) 2.8512 0.0912 
Malaria 42(10.4) 16(7.6) 1.2457 0.2644 
Gastroenteritis 15(3.7) 4(1.9) 1.5064 0.2197 
Intestinal Parasite 55(13.6) 38(18.1) 2.1591 0.1417 
Typhoid 4(1.0) 1(0.5) 0.4518 0.5015 
Sickle Cell Anemia 10(2.5) 3(1.4) 0.7304 0.3931 
Meningitis 1(0.25) 0 0.5206 0.4706 
          
Nutrition Status N=313 
All Children             n(%)     23.5174 <0.0006 
Normal                   96(15.6) 50(13.7) 46(23.6)     
Undernourished       518(84.4) 314(86.6) 149(74.4)     
          
Under-5      23.8516 0.0006 
Normal  16(7.8) 19(17.6)     
Undernourished: primary 39(19.0) 30(27.8)     
Undernourished: secondary 65(31.7) 31(28.7)     
Undernourished: tertiary 64(31.2) 15(13.9)     
Undernourished degree 
unknown 7(3.4) 9(8.3)     
Marasmus 10(4.8) 1(0.93)     
Kwashiorkor 4(2.0) 3(2.8)     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
§ Percentages of characteristics are based on non-missing values 
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Table 3:Crude Association of HIV with the EPTB Manifestation in 
TB-Infected Children  
Odds Ratio Estimates 
        
Effect  
Point 
Estimates 
95% Wald Confidence 
Limits   
HIV Status 0.323 0.188 0.555
Gender 0.668 0.477 0.936
Nutrition Status 0.781 0.689 0.884
Anemia 0.749 0.536 1.048
Malaria 0.711 0.39 1.297
Intestinal 
Parasite 1.402 0.892 2.203
 
 
 
Table 4: Adjusted Association of HIV with EPTB Manifestation in 
TB-infected Children 
Odds Ratio Estimates 
        
Effect  
Point 
Estimates 
95% Wald Confidence 
Limits   
HIV Status 0.431 0.228 0.749
Gender 0.689 0.467 1.018
Age 0.967 0.913 1.025
Nutrition 
Status 0.774 0.651 0.921
Anemia 1.05 0.709 1.557
Malaria 0.815 0.407 1.632
Intestinal 
Parasite 1.216 0.736 2.007
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
§HIV association is adjusted for all other covariates in the table 
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Table 5: Multivariate odds ratio for association of tabled 
characteristics with mortality 
Odds Ratio Estimates 
        
Effect  
Point 
Estimates 
95% Wald Confidence 
Limits   
HIV Status 4.179 1.625 10.751
PTB vs. EPTB 1.068 0.379 3.008
Gender 0.478 0.194 1.178
Age 0.93 0.792 1.091
Nutrition Status 2.139 1.492 3.065
Anemia 0.899 0.344 2.352
Malaria 1.436 0.454 4.537
Intestinal 
Parasite 1.736 0.504 5.981
 
 
 
Table 6: TB*HIV*Sputum Indicator n(%) 
  PTB EPTB 
HIV+ 33(37.1) 7(38.8) 
HIV- 44(16.6) 21(12.7) 
Not Tested for HIV 11(22) 4(15.4) 
 
 
 
 
 
 
 
§ Patients with no sputum record examination, n=120 
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Table A-1 
 
Timetable for Development of TB in HIV-Negative Cases 
Form of tuberculosis           Time from infection to onset      
Immune conversion 
Primary complex 
Local lung complications 
Pleural effusion (usually teenagers) 
Miliary/meningeal 
Bone 
Skin 
Renal 
Secondary breakdown 
4-8 weeks 
1-3 months 
3-9 months 
3-12 months 
3 months onwards 
10-36 months 
5 years onwards 
10 years onwards 
5 years onwards 
(Hoskyns, 2003) 
 
 
 
 
